SHZ:002020
Zhejiang Jingxin Pharmaceutical Co., Ltd. · SHZ · Healthcare · CNY · FY for 2025
Figures on this page computed 2026-11-08 12:44 UTC
Last close
n/aCNY
Market data
13.4xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
- Computed from the filing for 2025
13.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
18.6%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
14.2%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.05Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
2.8%Dividend yield
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- CNY
- computed
Growth is the furthest below its sector's middle: 0.37 against 0.47 on the market's range.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales1.22x
Its own average over 10 years, 3.34B.
- Profit1.41x
Its own average over 10 years, 537.1M.
- Free cash flow2.13x
Its own average over 10 years, 271.7M.
- Debt1.19x
Its own average over 10 years, 258.2M.
- Pricen/a
Its own average over 0 years. Market data
Free cash flow is furthest from its own average, at 2.13 times.
Sales is 1.22 times its own 10-year average; Profit is 1.41 times its own 10-year average; Free cash flow is 2.13 times its own 10-year average; Debt is 1.19 times its own 10-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 10-year average1.22
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Profit against its own 10-year average1.41
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Free cash flow against its own 10-year average2.13
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Debt against its own 10-year average1.19
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- CNY